Journals
Legacy
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Approves AstraZeneca's Gefurulimab (Klygefa) for Generalized MG
2
Deals Roundup: J&J Buys Ollin, Lilly Adds Calytrix, and Novartis and Sanofi Strike Platform Pacts
3
FDA Rejects Summit’s PD-1×VEGF Bispecific Ivonescimab in EGFR-Mutated NSCLC, Citing Lack of Survival Benefit
4
FDA's Rare Disease Framework Aims for Consistency Across Review Divisions, Says Former FDA Reviewer Paz Vellanki
5




